1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Cryomass Technologies Inc.

Cryomass Technologies Inc.

CRYM
Cryomass Technologies Inc.US flagOther OTC
0.00
USD
- -
- -
47,432.00Market Cap
Cryomass Technologies Inc.
CRYM
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
- -
- -
- -
- -
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
-0.01
-0.03
-0.12
-0.08
-0.05
-0.06
-0.04
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
-0.01
-0.02
-0.04
-0.04
-0.03
-0.02
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
-0.01
-0.04
-0.16
-0.18
-0.19
-0.25
-0.26
Book Value per Share
- -
- -
- -
- -
- -
- -
- -
0.01
0.05
0.04
0.05
- -
-0.03
-0.04
Tangible Book Value per Share
508
4,480
542
70
70
70
70
73
90
100
158
201
207
220
Basic Weighted Avg Shares
1
1
1
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
Sales/Revenue/Turnover
-3.63
-3.85
-5.01
- -
- -
- -
- -
- -
-18,264.63
-836.24
- -
- -
-43,824.19
-12,232.65
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
-3
-12
-13
-10
-13
-9
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-4.08
-3.49
-7.43
- -
- -
- -
- -
- -
-16,755.45
-1,512.04
- -
- -
-95,600.12
-23,363.61
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
13
4
5
1
-2
-7
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
2
3
1
LT Debt
- -
- -
- -
- -
- -
- -
- -
1
13
4
14
5
-6
-9
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-11.49
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'24
Sep'24
ST Debt
- -
3
3
LT Borrowings
3
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
211
235
237
Market Capitalization
7
8
6

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'24
Sep'24
Total Current Assets
- -
1
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
3
7
7
Payables & Accruals
3
3
4
ST Debt
- -
3
3
Deferred Revenue
- -
1
1

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
141.53%
366.56%
-227.87%
Free Cash Flow
-96,443.12%
43.39%
-24.92%
Net Income, GAAP
161.49%
183.18%
24.3%
Sales/Revenue/Turnover
- -
- -
-98.27%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-0.01
-0.01
-0.01
- -
-0.05
2023
-0.01
-0.03
-0.01
- -
-0.06
2024
-0.01
-0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Similar Companies
Integrated Pharmaceuticals, Inc. (INTP)
Juniper Pharmaceuticals, Inc. (JNP)
NxGen Brands Inc. (NXGB)
Kaken Pharmaceutical Co., Ltd. (4521.T)
Steep Hill Inc. (STPH.CN)
Galderma Group AG (GALD.SW)
Business
Cryomass Technologies Inc. (OTCQB: CRYM) develops and licenses proprietary cryogenic equipment and processes for refining harvested cannabis, hemp, and other premium trichome-rich crops. The company offers its flagship CryoSift Separator, a patented system that utilizes liquid nitrogen to flash-freeze biomass, reduce volume by up to 80%, and separate intact trichomes containing cannabinoids and terpenes; this solventless technology processes up to 700 pounds of fresh biomass per hour, eliminates drying and trimming steps, supports wet or dry feedstock including fresh frozen flower and trim, and enables superior extraction yields up to 4 times higher for processors. CryoMass generates revenue through equipment sales, non-exclusive patent licensing, and recurring processing fees based on biomass volume; it operates primarily in the United States and Canada, targeting cultivators, processors, and operators in the cannabis and hemp industries. Founded in 2011 and headquartered in Denver, Colorado, the company, formerly Andina Gold Corp., rebranded to Cryomass Technologies Inc. in August 2021 following its acquisition of key assets from Cryocann USA Corp., including US Patent #10,864,525 for cryogenic plant material separation. Recent developments include the February 2025 sale of its first two-skid production-model CryoSift Separator to a special purpose vehicle for deployment in Canada under a multi-year equipment lease and non-exclusive patent license agreement, generating one-time sale revenue plus ongoing processing fees; in the same month, CryoMass announced another sale of a production model unit to Tribe Collective in Oklahoma, facilitated by financing from NEC Financial Services, with concurrent patent licenses to Tribe and Choctaw operators providing potential annual recurring revenues exceeding $1 million per unit based on volume.

Company News

APIChatGPT

  • globenewswire.com

    CryoMass Announces Sale of CryoSift Separator™ and License of Its Cryogenic Refinement Technology in Oklahoma Market

  • globenewswire.com

    CryoMass Partners with Cannabis Powerhouse LEEF to Deploy Its Cryo Separation Technology

  • globenewswire.com

    CryoMass Announces Sale of First Production Model to be deployed in Canada

  • globenewswire.com

    CryoMass Announces Non-Dilutive Financing Agreement

  • globenewswire.com

    CryoMass Partners with California Manufacturer to Revolutionize Cannabinoid Production

  • globenewswire.com

    CryoMass provides update

  • headlinesoftoday.com

    CRYOMASS PREPARES FOR THE MARKET LAUNCH OF ITS REVOLUTIONARY TRICHOME SEPARATOR